DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Bajaj HS, Burrows M, Blavignac J. et al.
Extended-release naltrexone/bupropion and liver health: pooled, post hoc analysis from four randomized controlled trials.
Diabetes Obes Metab 2021;
23 (03) 861-865
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.